Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
Go back to Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 38.31 +1.22 (3.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.09 | 52 Week High | $66.55 | |||
| Open | $37.66 | 52 Week Low | $37.82 | |||
| Day High | $38.34 | P/E | N/A | |||
| Day Low | $37.00 | EPS | $0.00 | |||
| Volume | 832,697 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 38.31 +1.22 (3.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.09 | 52 Week High | $66.55 | |||
| Open | $37.66 | 52 Week Low | $37.82 | |||
| Day High | $38.34 | P/E | N/A | |||
| Day Low | $37.00 | EPS | $0.00 | |||
| Volume | 832,697 | |||||
